The University of Kentucky's Cardiovascular Biorepository provides a comprehensive collection of human heart tissue samples for research into end-stage heart failure. Ideal for collaborations with industry, the biobank includes samples from organ donors and patients with ventricular assist devices.
The University of Kentucky Cardiovascular Biorepository offers a unique resource for researchers focused on cardiovascular diseases, specifically end-stage heart failure. The biobank includes approximately 10,800 samples from 550 individuals, incorporating both control samples from organ donors and samples from patients with end-stage heart failure who have received ventricular assist devices or cardiac transplants. This invaluable collection is ideal for collaborative research initiatives with industry partners looking to advance cardiovascular therapies and diagnostics.
This biorepository is at Technology Readiness Level 6, indicating that the samples and associated protocols have been validated in relevant environments and are ready for further industry collaboration and research applications.
The University of Kentucky is a comprehensive public, land‑grant research university and the Commonwealth’s flagship, anchored in Lexington with a major academic medical center and statewide reach. Industry engages through an affiliated research and technology park with multi‑tenant labs and direct access to campus experts. Integration with a major hospital system enables clinical studies and data‑driven translation, while a Cooperative Extension network connects R&D to communities across Kentucky. Research is supported by competitive federal funding from agencies such as NIH, NSF, USDA, and DOE alongside corporate and state partnerships. A dedicated tech transfer office provides IP management, licensing, startup support, and industry contracting to accelerate commercialization.